Skip to main content
OpenTrials

Clinical trial condition

Diffuse-large B-cell Lymphoma (DLBCL)

Explore clinical trials studying Diffuse-large B-cell Lymphoma (DLBCL). Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Diffuse-large B-cell Lymphoma (DLBCL) trial results

Recruiting

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

NCT06980116

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
Locations
  • LLC ARENSIA Exploratory Medicine Tbilisi, Georgia
  • IMSP Institute of Oncology, ARENSIA Exploratory Medicine Chisinau, Moldova
  • Hospital Beata Maria Ana Madrid, Spain
  • Hospital Fundación Jiménez Diaz Madrid, Spain
View Trial Details
Completed

A Study of CC-97540, CD19-targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in Subjects With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT04231747

Conditions
Agressive Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Diffuse-large B-cell Lymphoma (DLBCL), +13 more
Locations
  • Local Institution - 003 Birmingham, Alabama, United States
  • Local Institution - 004 Atlanta, Georgia, United States
  • Local Institution - 011 Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 14 locations
View Trial Details

Related conditions